secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMERICAN VANGUARD CORP (AVD)
CIK:        0000005981
Form:       8-K
Filed at:   2024-05-10T23:59:59+00:00
Accession:  0001193125-24-136157
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

American Vanguard Q1 net sales up 8% to $135M; adjusted EBITDA up 35% to $15.5M; guides FY adjusted EBITDA $60-70M
--------------------------------------------------------------------------------

- Net sales $135M (+8% YoY); diluted EPS $0.06 vs $0.07; net income $1.6M vs $1.9M.
- Adjusted EBITDA $15.5M (+35%); operating income $6.1M (+87%); transformation program targets $15M annualized EBITDA by 2026.
- FY guidance: net sales growth 6-9%, adjusted EBITDA $60-70M.
- Voluntarily suspended Dacthal herbicide sales pending EPA label resolution; cites USEPA concerns.
- Growth across all three segments (US Crop, US Non-crop, International); destocking subsiding but channel remains cautious.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/5981/000119312524136157/0001193125-24-136157-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/5981/000119312524136157/d770184d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-136157

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer